FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to substituted 4-(1,2,3,4-tetrahydro-1- -naphthalenyl)-1H-imidazoles and 4-(2,3-dihydro-1H-indene-1-yl)-1H-imidazoles of the general formula (I) where n = 1, 2; R1, R2, R3, R4 are similar or different and each is hydrogen or halogen atom, hydroxyl, alkyl or alkoxyl radical; R5 is hydrogen or alkyl under condition that R1, R2, R3, R4 and R5 can not be hydrogen atom simultaneously if n = 2, and their additive salts with nontoxic pharmaceutically acceptable acids also. Compounds show properties of α2-presynaptic agonists and α1-postsynaptic antagonists and can be used for prophylaxis and treatment of patients with disorders resulting to acute myocardium ischemia. Invention describes three methods of synthesis of compounds of the formula (I). EFFECT: improved method of synthesis, valuable pharmacological and medicinal properties of compounds. 17 cl, 4 tbl, 3 ex
Authors
Dates
2000-09-20—Published
1995-12-13—Filed